In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...

CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...

American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...

Markets have hardly recovered from the DeepSeek shock and have just met trade tariff headwinds. Nonetheless, these stocks are ...

Markets have hardly recovered from the DeepSeek shock and have just met trade tariff headwinds. Nonetheless, these stocks are ...

GlaxoSmithKline plc (NYSE: NYSE:GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst estimates, despite earnings falling short of expectations.

GlaxoSmithKline (GSK) continues to be the subject of takeover ... a far cry from the middle of 2013 when the stock was trading at a little below 1,750 pence. Last year's corruption scandal in ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

GlaxoSmithKline Pharmaceuticals ... On previous day, the GSK Pharma Share Price (NSE) closed at Rs. 1956.2, featuring among the most traded securities on the National Stock Exchange.

The highest price of Glaxosmithkline Pharmaceuticals Ltd stock is ₹3,088.00 in the last ... has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030 ...